View Future GrowthSBSUNGBO 과거 순이익 실적과거 기준 점검 3/6SBSUNGBO은 연평균 67.3%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 0.3% 감소했습니다. 매출은 연평균 1.7%의 비율로 증가했습니다. SBSUNGBO의 자기자본이익률은 21.6%이고 순이익률은 53%입니다.핵심 정보67.30%순이익 성장률67.38%주당순이익(EPS) 성장률Chemicals 산업 성장률13.95%매출 성장률1.67%자기자본이익률21.57%순이익률53.03%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트분석 기사 • May 24We Don’t Think SBSUNGBO's (KRX:003080) Earnings Should Make Shareholders Too ComfortableSBSUNGBO Co., Ltd. ( KRX:003080 ) posted some decent earnings, but shareholders didn't react strongly. We think that...분석 기사 • Aug 24We Think Shareholders Should Be Aware Of Some Factors Beyond SBSUNGBO's (KRX:003080) ProfitDespite posting strong earnings, SBSUNGBO Co., Ltd.'s ( KRX:003080 ) stock didn't move much over the last week. We...Reported Earnings • Mar 22Full year 2024 earnings released: ₩176 loss per share (vs ₩65.00 profit in FY 2023)Full year 2024 results: ₩176 loss per share (down from ₩65.00 profit in FY 2023). Revenue: ₩59.8b (down 4.4% from FY 2023). Net loss: ₩3.44b (down 370% from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance.Reported Earnings • Nov 20Third quarter 2024 earnings released: ₩158 loss per share (vs ₩120 loss in 3Q 2023)Third quarter 2024 results: ₩158 loss per share (further deteriorated from ₩120 loss in 3Q 2023). Revenue: ₩7.18b (up 8.8% from 3Q 2023). Net loss: ₩3.10b (loss widened 30% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings.Reported Earnings • Mar 16Full year 2023 earnings released: EPS: ₩65.00 (vs ₩204 in FY 2022)Full year 2023 results: EPS: ₩65.00 (down from ₩204 in FY 2022). Revenue: ₩62.6b (down 5.7% from FY 2022). Net income: ₩1.28b (down 68% from FY 2022). Profit margin: 2.0% (down from 6.0% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩204 (vs ₩69.00 in FY 2021)Full year 2022 results: EPS: ₩204 (up from ₩69.00 in FY 2021). Revenue: ₩66.4b (up 15% from FY 2021). Net income: ₩4.01b (up 195% from FY 2021). Profit margin: 6.0% (up from 2.4% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.모든 업데이트 보기Recent updates분석 기사 • May 24We Don’t Think SBSUNGBO's (KRX:003080) Earnings Should Make Shareholders Too ComfortableSBSUNGBO Co., Ltd. ( KRX:003080 ) posted some decent earnings, but shareholders didn't react strongly. We think that...공시 • Mar 13SBSUNGBO Co., Ltd., Annual General Meeting, Mar 26, 2026SBSUNGBO Co., Ltd., Annual General Meeting, Mar 26, 2026, at 11:00 Tokyo Standard Time. Location: conference room, 517, jukhwa-ro, gyeonggi-do, anseong South KoreaNew Risk • Nov 23New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 69% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (69% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₩57.7b market cap, or US$39.2m).분석 기사 • Aug 24We Think Shareholders Should Be Aware Of Some Factors Beyond SBSUNGBO's (KRX:003080) ProfitDespite posting strong earnings, SBSUNGBO Co., Ltd.'s ( KRX:003080 ) stock didn't move much over the last week. We...Reported Earnings • Mar 22Full year 2024 earnings released: ₩176 loss per share (vs ₩65.00 profit in FY 2023)Full year 2024 results: ₩176 loss per share (down from ₩65.00 profit in FY 2023). Revenue: ₩59.8b (down 4.4% from FY 2023). Net loss: ₩3.44b (down 370% from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance.공시 • Mar 12Sung Bo Chemicals Co., LTD, Annual General Meeting, Mar 26, 2025Sung Bo Chemicals Co., LTD, Annual General Meeting, Mar 26, 2025, at 11:00 Tokyo Standard Time. Location: conference room, 517, jukhwa-ro, iljuk-myeon, gyeonggi-do, anseong South KoreaUpcoming Dividend • Dec 20Upcoming dividend of ₩135 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 16 April 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 5.3%. Within top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%).New Risk • Dec 07New minor risk - Financial data availabilityLess than 3 years of financial data is available. This is considered a minor risk. If the company has been trading for less than 3 years, then it has not had the opportunity to establish a long-term track record. This makes it difficult for investors to assess the true growth potential, sustainability and resilience of the business under different economic conditions. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-₩21b). Less than 3 years of financial data is available. Market cap is less than US$100m (₩48.8b market cap, or US$34.3m).Declared Dividend • Nov 27Dividend of ₩135 announcedShareholders will receive a dividend of ₩135. Ex-date: 27th December 2024 Payment date: 16th April 2025 Dividend yield will be 5.3%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 4 years but payments have been stable during that time.Reported Earnings • Nov 20Third quarter 2024 earnings released: ₩158 loss per share (vs ₩120 loss in 3Q 2023)Third quarter 2024 results: ₩158 loss per share (further deteriorated from ₩120 loss in 3Q 2023). Revenue: ₩7.18b (up 8.8% from 3Q 2023). Net loss: ₩3.10b (loss widened 30% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings.Reported Earnings • Mar 16Full year 2023 earnings released: EPS: ₩65.00 (vs ₩204 in FY 2022)Full year 2023 results: EPS: ₩65.00 (down from ₩204 in FY 2022). Revenue: ₩62.6b (down 5.7% from FY 2022). Net income: ₩1.28b (down 68% from FY 2022). Profit margin: 2.0% (down from 6.0% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.Upcoming Dividend • Dec 20Upcoming dividend of ₩135 per share at 4.5% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 19 April 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.5%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).New Risk • Nov 25New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 40% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 135% Paying a dividend despite having no free cash flows. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.1% net profit margin). Market cap is less than US$100m (₩58.2b market cap, or US$44.7m).Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₩3,420, the stock trades at a trailing P/E ratio of 52.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 8.6% over the past three years.New Risk • Aug 28New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 209% The company is paying a dividend despite having no free cash flows. Dividend yield: 4.6% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 209% Paying a dividend despite having no free cash flows. Minor Risks Profit margins are more than 30% lower than last year (2.0% net profit margin). Market cap is less than US$100m (₩58.1b market cap, or US$43.9m).Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩204 (vs ₩69.00 in FY 2021)Full year 2022 results: EPS: ₩204 (up from ₩69.00 in FY 2021). Revenue: ₩66.4b (up 15% from FY 2021). Net income: ₩4.01b (up 195% from FY 2021). Profit margin: 6.0% (up from 2.4% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Dec 21Upcoming dividend of ₩120 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 24 April 2023. Payout ratio is a comfortable 47% but the company is not cash flow positive. Trailing yield: 3.7%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Jun 22Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₩4,665, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Negligible returns to shareholders over past three years.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Mar 13Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: ₩69.00 (up from ₩306 loss in FY 2020). Revenue: ₩57.7b (up 12% from FY 2020). Net income: ₩1.36b (up ₩7.35b from FY 2020). Profit margin: 2.4% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue missed analyst estimates by 2.2%.Upcoming Dividend • Dec 22Upcoming dividend of ₩135 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 25 April 2022. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.4%. Within top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%).분석 기사 • Apr 06We Think Sung Bo Chemicals (KRX:003080) Can Easily Afford To Drive Business GrowthJust because a business does not make any money, does not mean that the stock will go down. For example, although...Reported Earnings • Mar 12Full year 2020 earnings released: ₩306 loss per share (vs ₩145 loss in FY 2019)The company reported a soft full year result with increased losses and weaker control over costs, although revenues improved. Full year 2020 results: Revenue: ₩51.7b (up 24% from FY 2019). Net loss: ₩5.99b (loss widened 109% from FY 2019).분석 기사 • Mar 11Introducing Sung Bo Chemicals (KRX:003080), A Stock That Climbed 64% In The Last YearIt's always best to build a diverse portfolio of shares, since any stock business could lag the broader market. But the...Is New 90 Day High Low • Feb 20New 90-day low: ₩4,210The company is down 1.0% from its price of ₩4,270 on 20 November 2020. The South Korean market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 23% over the same period.Is New 90 Day High Low • Jan 19New 90-day high: ₩4,700The company is up 11% from its price of ₩4,220 on 21 October 2020. The South Korean market is up 26% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 35% over the same period.Is New 90 Day High Low • Dec 12New 90-day high: ₩4,495The company is up 4.0% from its price of ₩4,320 on 11 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.Is New 90 Day High Low • Oct 26New 90-day low: ₩4,070The company is down 7.0% from its price of ₩4,400 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.Is New 90 Day High Low • Sep 23New 90-day low: ₩4,135The company is down 14% from its price of ₩4,815 on 25 June 2020. The South Korean market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 27% over the same period.매출 및 비용 세부 내역SBSUNGBO가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSE:A003080 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비31 Mar 2663,74833,80517,8972,55231 Dec 2564,33434,45217,3982,53730 Sep 2564,49641,01416,8012,44230 Jun 2564,95541,69316,0912,40331 Mar 2564,122-4,42215,3172,07431 Dec 2459,838-3,44215,0121,97830 Sep 2461,105-39214,0762,02830 Jun 2460,52633014,2701,50531 Mar 2461,34872414,2121,51431 Dec 2362,6121,27713,6232,03430 Sep 2363,3921,95914,3912,02530 Jun 2362,4131,27214,0572,02531 Mar 2364,0383,02313,6961,99231 Dec 2266,3794,01512,8651,96030 Sep 2264,1345,07211,6011,75930 Jun 2264,5826,45711,0271,75931 Mar 2263,4334,71610,9831,75231 Dec 2157,6761,36110,4971,58930 Sep 2156,993-6,89010,6091,78730 Jun 2156,899-5,99810,8401,78731 Mar 2156,128-5,9719,5562,45531 Dec 2051,734-5,99210,3312,08630 Sep 2050,262-1,6949,9561,96930 Jun 2048,812-2,5318,6722,51931 Dec 1941,864-2,8689,4192,298양질의 수익: A003080의 비현금 수익 수준이 높습니다.이익 마진 증가: A003080는 과거에 흑자전환했습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: A003080는 지난 5년 동안 흑자전환하며 연평균 67.3%의 수익 성장을 기록했습니다.성장 가속화: A003080는 지난해 흑자전환하여 5년 평균과 수익 성장률을 비교하기 어렵습니다.수익 대 산업: A003080는 지난해 흑자전환하여 지난 해 수익 성장률을 Chemicals 업계(-3.5%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: A003080의 자본 수익률(21.6%)은 높음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/29 07:26종가2026/06/29 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스SBSUNGBO Co., Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
분석 기사 • May 24We Don’t Think SBSUNGBO's (KRX:003080) Earnings Should Make Shareholders Too ComfortableSBSUNGBO Co., Ltd. ( KRX:003080 ) posted some decent earnings, but shareholders didn't react strongly. We think that...
분석 기사 • Aug 24We Think Shareholders Should Be Aware Of Some Factors Beyond SBSUNGBO's (KRX:003080) ProfitDespite posting strong earnings, SBSUNGBO Co., Ltd.'s ( KRX:003080 ) stock didn't move much over the last week. We...
Reported Earnings • Mar 22Full year 2024 earnings released: ₩176 loss per share (vs ₩65.00 profit in FY 2023)Full year 2024 results: ₩176 loss per share (down from ₩65.00 profit in FY 2023). Revenue: ₩59.8b (down 4.4% from FY 2023). Net loss: ₩3.44b (down 370% from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance.
Reported Earnings • Nov 20Third quarter 2024 earnings released: ₩158 loss per share (vs ₩120 loss in 3Q 2023)Third quarter 2024 results: ₩158 loss per share (further deteriorated from ₩120 loss in 3Q 2023). Revenue: ₩7.18b (up 8.8% from 3Q 2023). Net loss: ₩3.10b (loss widened 30% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Mar 16Full year 2023 earnings released: EPS: ₩65.00 (vs ₩204 in FY 2022)Full year 2023 results: EPS: ₩65.00 (down from ₩204 in FY 2022). Revenue: ₩62.6b (down 5.7% from FY 2022). Net income: ₩1.28b (down 68% from FY 2022). Profit margin: 2.0% (down from 6.0% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩204 (vs ₩69.00 in FY 2021)Full year 2022 results: EPS: ₩204 (up from ₩69.00 in FY 2021). Revenue: ₩66.4b (up 15% from FY 2021). Net income: ₩4.01b (up 195% from FY 2021). Profit margin: 6.0% (up from 2.4% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
분석 기사 • May 24We Don’t Think SBSUNGBO's (KRX:003080) Earnings Should Make Shareholders Too ComfortableSBSUNGBO Co., Ltd. ( KRX:003080 ) posted some decent earnings, but shareholders didn't react strongly. We think that...
공시 • Mar 13SBSUNGBO Co., Ltd., Annual General Meeting, Mar 26, 2026SBSUNGBO Co., Ltd., Annual General Meeting, Mar 26, 2026, at 11:00 Tokyo Standard Time. Location: conference room, 517, jukhwa-ro, gyeonggi-do, anseong South Korea
New Risk • Nov 23New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 69% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (69% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (₩57.7b market cap, or US$39.2m).
분석 기사 • Aug 24We Think Shareholders Should Be Aware Of Some Factors Beyond SBSUNGBO's (KRX:003080) ProfitDespite posting strong earnings, SBSUNGBO Co., Ltd.'s ( KRX:003080 ) stock didn't move much over the last week. We...
Reported Earnings • Mar 22Full year 2024 earnings released: ₩176 loss per share (vs ₩65.00 profit in FY 2023)Full year 2024 results: ₩176 loss per share (down from ₩65.00 profit in FY 2023). Revenue: ₩59.8b (down 4.4% from FY 2023). Net loss: ₩3.44b (down 370% from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance.
공시 • Mar 12Sung Bo Chemicals Co., LTD, Annual General Meeting, Mar 26, 2025Sung Bo Chemicals Co., LTD, Annual General Meeting, Mar 26, 2025, at 11:00 Tokyo Standard Time. Location: conference room, 517, jukhwa-ro, iljuk-myeon, gyeonggi-do, anseong South Korea
Upcoming Dividend • Dec 20Upcoming dividend of ₩135 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 16 April 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 5.3%. Within top quartile of South Korean dividend payers (3.9%). Higher than average of industry peers (2.2%).
New Risk • Dec 07New minor risk - Financial data availabilityLess than 3 years of financial data is available. This is considered a minor risk. If the company has been trading for less than 3 years, then it has not had the opportunity to establish a long-term track record. This makes it difficult for investors to assess the true growth potential, sustainability and resilience of the business under different economic conditions. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-₩21b). Less than 3 years of financial data is available. Market cap is less than US$100m (₩48.8b market cap, or US$34.3m).
Declared Dividend • Nov 27Dividend of ₩135 announcedShareholders will receive a dividend of ₩135. Ex-date: 27th December 2024 Payment date: 16th April 2025 Dividend yield will be 5.3%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 4 years but payments have been stable during that time.
Reported Earnings • Nov 20Third quarter 2024 earnings released: ₩158 loss per share (vs ₩120 loss in 3Q 2023)Third quarter 2024 results: ₩158 loss per share (further deteriorated from ₩120 loss in 3Q 2023). Revenue: ₩7.18b (up 8.8% from 3Q 2023). Net loss: ₩3.10b (loss widened 30% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Mar 16Full year 2023 earnings released: EPS: ₩65.00 (vs ₩204 in FY 2022)Full year 2023 results: EPS: ₩65.00 (down from ₩204 in FY 2022). Revenue: ₩62.6b (down 5.7% from FY 2022). Net income: ₩1.28b (down 68% from FY 2022). Profit margin: 2.0% (down from 6.0% in FY 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 78% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Dec 20Upcoming dividend of ₩135 per share at 4.5% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 19 April 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.5%. Within top quartile of South Korean dividend payers (3.5%). Higher than average of industry peers (1.8%).
New Risk • Nov 25New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 40% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 135% Paying a dividend despite having no free cash flows. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.1% net profit margin). Market cap is less than US$100m (₩58.2b market cap, or US$44.7m).
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₩3,420, the stock trades at a trailing P/E ratio of 52.9x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total loss to shareholders of 8.6% over the past three years.
New Risk • Aug 28New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 209% The company is paying a dividend despite having no free cash flows. Dividend yield: 4.6% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 209% Paying a dividend despite having no free cash flows. Minor Risks Profit margins are more than 30% lower than last year (2.0% net profit margin). Market cap is less than US$100m (₩58.1b market cap, or US$43.9m).
Reported Earnings • Mar 14Full year 2022 earnings released: EPS: ₩204 (vs ₩69.00 in FY 2021)Full year 2022 results: EPS: ₩204 (up from ₩69.00 in FY 2021). Revenue: ₩66.4b (up 15% from FY 2021). Net income: ₩4.01b (up 195% from FY 2021). Profit margin: 6.0% (up from 2.4% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Dec 21Upcoming dividend of ₩120 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 24 April 2023. Payout ratio is a comfortable 47% but the company is not cash flow positive. Trailing yield: 3.7%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (2.4%).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Jun 22Investor sentiment improved over the past weekAfter last week's 24% share price gain to ₩4,665, the stock trades at a trailing P/E ratio of 19.5x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Negligible returns to shareholders over past three years.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Mar 13Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: ₩69.00 (up from ₩306 loss in FY 2020). Revenue: ₩57.7b (up 12% from FY 2020). Net income: ₩1.36b (up ₩7.35b from FY 2020). Profit margin: 2.4% (up from net loss in FY 2020). The move to profitability was primarily driven by higher revenue. Revenue missed analyst estimates by 2.2%.
Upcoming Dividend • Dec 22Upcoming dividend of ₩135 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 25 April 2022. The company is not currently making a profit but it is cash flow positive. Trailing yield: 3.4%. Within top quartile of South Korean dividend payers (2.4%). Higher than average of industry peers (1.5%).
분석 기사 • Apr 06We Think Sung Bo Chemicals (KRX:003080) Can Easily Afford To Drive Business GrowthJust because a business does not make any money, does not mean that the stock will go down. For example, although...
Reported Earnings • Mar 12Full year 2020 earnings released: ₩306 loss per share (vs ₩145 loss in FY 2019)The company reported a soft full year result with increased losses and weaker control over costs, although revenues improved. Full year 2020 results: Revenue: ₩51.7b (up 24% from FY 2019). Net loss: ₩5.99b (loss widened 109% from FY 2019).
분석 기사 • Mar 11Introducing Sung Bo Chemicals (KRX:003080), A Stock That Climbed 64% In The Last YearIt's always best to build a diverse portfolio of shares, since any stock business could lag the broader market. But the...
Is New 90 Day High Low • Feb 20New 90-day low: ₩4,210The company is down 1.0% from its price of ₩4,270 on 20 November 2020. The South Korean market is up 19% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 23% over the same period.
Is New 90 Day High Low • Jan 19New 90-day high: ₩4,700The company is up 11% from its price of ₩4,220 on 21 October 2020. The South Korean market is up 26% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 35% over the same period.
Is New 90 Day High Low • Dec 12New 90-day high: ₩4,495The company is up 4.0% from its price of ₩4,320 on 11 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.
Is New 90 Day High Low • Oct 26New 90-day low: ₩4,070The company is down 7.0% from its price of ₩4,400 on 28 July 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.
Is New 90 Day High Low • Sep 23New 90-day low: ₩4,135The company is down 14% from its price of ₩4,815 on 25 June 2020. The South Korean market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 27% over the same period.